SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0000912057-02-013121
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
12
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10KSB a2075341z10ksb.htm 10KSB 656874
3 EXHIBIT 10.4 a2075341zex-10_4.txt EX-10.4 7811
4 EXHIBIT 10.5 a2075341zex-10_5.txt EX-10.5 72859
5 EXHIBIT 10.20 a2075341zex-10_20.txt EX-10.20 27901
6 EXHIBIT 10.24 a2075341zex-10_24.txt EX-10.24 3141
7 EXHIBIT 10.28 a2075341zex-10_28.txt EX-10.28 27500
8 EXHIBIT 10.29 a2075341zex-10_29.txt EX-10.29 19094
9 EXHIBIT 10.30 a2075341zex-10_30.txt EX-10.30 16556
10 EXHIBIT 21.1 a2075341zex-21_1.txt EX-21.1 1103
11 EXHIBIT 23.1 a2075341zex-23_1.htm EX-23.1 1807
12 EXHIBIT 23.2 a2075341zex-23_2.htm EX-23.2 1300
13 EXHIBIT 24.1 a2075341zex-24_1.txt EX-24.1 2545
  Complete submission text file 0000912057-02-013121.txt   841479
Mailing Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045
Business Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045 847-573-8990
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 000-16929 | Film No.: 02598583
SIC: 2834 Pharmaceutical Preparations